Effectiveness of resuming ustekinumab therapy in psoriasis patients with metabolic disorders. Clinical experience
Psoriasis is a chronic immune-mediated inflammatory skin disease with possible damage to the musculoskeletal system, affecting 2-3 % of the adult population of the planet. To date, special attention in the treatment of psoriasis is paid to the comorbid background, since it is known that it can aggra...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
State Scientific Center of Dermatovenereology and Cosmetology
2019-02-01
|
| Series: | Vestnik Dermatologii i Venerologii |
| Subjects: | |
| Online Access: | https://www.vestnikdv.ru/jour/article/view/443 |